12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dotarem gadoterate meglumine regulatory update

FDA approved Dotarem gadoterate meglumine from Guerbet for use in MRI imaging to detect and visualize areas with disruption of...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >